Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Sales | 1,530 | 1,030 | 320 | 890 | 1,150 |
| Gross Profit | 1,520 | 1,020 | 320 | 890 | 1,150 |
| Operating Expenses | 5,020 | 4,750 | 5,540 | 4,830 | 5,660 |
| Operating Income | -3,490 | -3,720 | -5,220 | -3,940 | -4,510 |
| Interest Expense | 2 | 0 | 6 | 1 | 1 |
| Other Income | 162 | 150 | 206 | 211 | -249 |
| Pre-tax Income | -3,330 | -3,570 | -5,020 | -3,730 | -4,760 |
| Income Tax | 0 | 0 | 0 | -230 | -50 |
| Net Income Continuous | -3,337 | -3,572 | -5,020 | -3,490 | -4,710 |
| Net Income | $-3,337 | $-3,572 | $-5,020 | $-3,490 | $-4,710 |
| EPS Basic Total Ops | -0.24 | -1.44 | N/A | -2.52 | N/A |
| EPS Basic Continuous Ops | -0.22 | -1.44 | N/A | -2.46 | N/A |
| EPS Diluted Total Ops | -0.24 | -1.44 | N/A | -2.52 | N/A |
| EPS Diluted Continuous Ops | -0.22 | -1.44 | N/A | -2.46 | N/A |
| EBITDA(a) | $-3,410 | $-3,630 | $-5,130 | $-3,710 | $-4,490 |